Measurement of exhaled alveolar nitrogen oxide in patients with lung cancer: a friend from the past still precious today
- PMID: 23807853
- PMCID: PMC3686538
- DOI: 10.2147/OTT.S44087
Measurement of exhaled alveolar nitrogen oxide in patients with lung cancer: a friend from the past still precious today
Abstract
Nitric oxide (NO) is a marker of airway inflammation and indirectly a general indicator of inflammation and oxidative stress. NO is a contributing factor in lung cancer at an early stage and also after chemotherapy treatment of lung cancer. We studied whether exhaled NO levels were altered by three cycles of chemotherapy at diagnosis and after chemotherapy, and whether, directly or indirectly, these changes were related to the course of disease. Also, a correlation of NO levels with other markers of inflammation was performed. We studied 42 patients diagnosed early: 26 men and 16 women with lung cancer. We analyzed blood tests for control of inflammatory markers, functional pulmonary tests, and alveolar exhaled NO. We recorded a decrease in exhaled NO after three cycles of chemotherapy in all patients, regardless of histological type and stage: there were 42 patients with mean 9.8 NO after three cycles (average 7.7). Also, a strong correlation appeared between NO measurements before and after chemotherapy and C-reactive protein (P < 0.05, r = 0.42, before) and (P < 0.045, r = 0.64, after). NO alveolar measurement as an indicator of airway inflammation indicates response to chemotherapy in lung cancer. Also, the inflammatory process in lung cancer was confirmed and indicated response to chemotherapy through an index that is sensitive to inflammatory disease of the airways.
Keywords: inflammation; lung cancer; nitric oxide.
References
-
- Samet JM, Albert AJ, Ford JG. Epidemiology of lung cancer and mesothelioma. Eur Respir Soc Monogr. 2009;44:349–391.
-
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–249. - PubMed
-
- Kontakiotis T, Manolakoglou N, Zoglopitis F, et al. Epidemiologic trends in lung cancer over two decades in Northern Greece: an analysis of bronchoscopic data. Monaldi Arch Chest Dis. 2009;71:147–152. - PubMed
-
- Wistuba II, Liao Z, Milas L. Molecular biology of lung cancer. In: Syrigos KN, Nutting CH, Roussos C, editors. Tumors of the Chest. Berlin: Springer; 2006.
-
- Politi EN, Syrigos KN. Preneoplastic lesions of the lung. In: Syrigos KN, Nutting CH, Roussos C, editors. Tumors of the Chest. Berlin: Springer; 2006.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
